These findings suggest that AF, due to its strong dual agonistic action toward PPARα and PPARγ, along with the glucose uptake enhancing effect, might ameliorate hyperlipidemia and hyperglycemia without the adverse effect of weight gain and increased adipogenesis. This evidence concerns the gene PPARG and atrial fibrillation.